Shufro Rose & CO LLC Teva Pharmaceutical Industries LTD Transaction History

Shufro Rose & CO LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 01, 2019	SELL	$14.59 - $23.84 $244,805 - $400,011	-16,779 Closed	0 $0
Q3 2018 Oct 26, 2018	SELL	$21.06 - $25.65 $2,106 - $2,565	-100 Reduced 0.59%	16,779 $361,000
Q2 2018 Jul 27, 2018	SELL	$16.77 - $24.71 $13,416 - $19,768	-800 Reduced 4.53%	16,879 $410,000
Q1 2018 May 04, 2018	SELL	$16.68 - $22.07 $667 - $882	-40 Reduced 0.23%	17,679 $302,000
Q4 2017 Feb 06, 2018	SELL	$11.23 - $19.1 $92,366 - $157,097	-8,225 Reduced 31.7%	17,719 $336,000
Q3 2017 Nov 13, 2017	BUY	$15.41 - $32.17 $399,797 - $834,618	25,944	25,944 $457,000

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $25.1B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Shufro Rose & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Shufro Rose & CO LLC with notifications on news.